Pharnext Logo

Pharnext

ISIN

FR0011191287

Ticker

ALPHA

Sector

Health Care

Sub-Industry

Biotechnology

Country

France

Year Founded

2007

About Pharnext

Company Description

Our company

Pharnext is an advanced clinical-stage biopharmaceutical company developing novel therapeutics for neurodegenerative diseases with high unmet medical needs.

Our drug Candidates

Two drug candidates are currently in clinical development: PXT3003 for the treatment of Charcot-Marie-Tooth disease type 1A and PXT864 for Alzheimer’s disease. Both of our lead assets originated from the Pleotherapy R&D approach.

Headcount

44

Served Area

Worldwide

Headquarters

46 Rue Saint Lazare
75009, Paris
France

Capital Markets Information

ISIN

FR0011191287

LEI

969500KJGF9ZUYXSMJ27

Sub-Industry

Biotechnology

Listed Stock Exchange

Euronext Paris

Contact Investor Relations Department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.